This inventor holds 2 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1997-1998.
Location History:
- Bethlehem, PA (US) (1997)
- Rahway, NJ (US) (1998)
Company Filing History:
Years Active: 1997-1998
Title: The Innovations of Kimberly L. Folander
Introduction
Kimberly L. Folander is a notable inventor based in Bethlehem, PA (US). She has made significant contributions to the field of biotechnology, particularly in the area of potassium channels. With a total of 2 patents, her work has implications for various medical conditions.
Latest Patents
Her latest patents include groundbreaking research on DNA encoding the beta subunit of a mammalian maxi-K potassium channel. This invention involves a screening array using cells that express recombinant alpha and beta subunits. The disclosed nucleic acids encode the beta subunit of the mammalian large-conductance ('maxi-K') potassium channel. The invention also includes recombinant host cells that express alpha-beta heteromultimers. These cells or preparations derived from them can be utilized to screen for pharmacologically active modulators of maxi-K channel activity. Such modulators hold potential for treating conditions like asthma, hypertension, angina, cerebral ischemia, and even Alzheimer's disease.
Career Highlights
Kimberly is currently employed at Merck & Co., Inc., where she continues to advance her research. Her work is pivotal in developing therapies that could significantly improve patient outcomes in various health conditions.
Collaborations
Some of her notable coworkers include Gregory J. Kaczorowski and Maria L. Garcia, who contribute to her innovative projects and research endeavors.
Conclusion
Kimberly L. Folander's contributions to the field of biotechnology through her patents and research at Merck & Co., Inc. highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has the potential to improve the lives of many individuals suffering from serious health conditions.